Analysts Issue Research Notes On Cerus Corporation (CERS)

Cerus Corporation (NASDAQ:CERS) finished Wednesday with a subtraction of -$0.1 to close at $1.95, a downside of -4.65 percent. An average of 1,706,320 shares of common stock have been traded in the last five days. There was a fall of -$1.03 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 1,173,510 shares traded, while the 50-day average volume stands at 1,305,592.

CERS stock has decreased by -19.75% in the last month. The company shares reached their 1-month lowest point of $1.94 on 08/09/23. With the stock rallying to its 52-week high on 01/05/23, shares of the company touched a low of $1.76 and a high of $5.66 in 52 weeks. It has reached a new high 3 times so far this year and lost -46.58% or -$1.70 in price. In spite of this, the price is down -65.52% from the 52-week high.

Insider Transactions

CERS stock investors should be aware that Cerus Corporation (CERS) stock had its last reported insider trading activity 150 days ago on May 26. In this transaction, the insider spent $169,344. Chief Operating Officer, Jayaraman Vivek K, disposed of 25,356 shares at a price of $2.80 on Mar 13. The insider now owns more than $70,997 worth of shares. Prior to that, Chief Medical Officer Benjamin Richard J went on to Sale 25,353 shares at $2.79 each on Mar 13. An amount of $70,781 was transacted.

Valuation Metrics

Cerus Corporation (CERS) stock’s beta is 1.10. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.92, the price-to-book (PB) ratio at 5.91.

Financial Health

The quick ratio of Cerus Corporation for the three months ended June 29 was 1.60, and the current ratio was 2.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.94 and a total debt to equity ratio of 1.24 for the quarter ending June 29. Cerus Corporation’s EBITDA margin for the year ending June 29 is -34.43%, while its operating margin for the same period stands at -18.60%. Its gross profit as reported stood at $113.36 million compared to revenue of $188.31 million.

Earnings Surprise

For the three-month period that ended June 29, Cerus Corporation had $63.87 million in cash and short-term investments compared to $54.84 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$13.28 million in the quarter, while revenues of -$15.62 million were grew 36.82%. The analyst consensus anticipated Cerus Corporation’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.06, a 0.00% surprise. For the quarter, EBITDA amounted to -$11.0 million. Shareholders own equity worth $180.8 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Cerus Corporation (CERS) price momentum. RSI 9-day as of the close on 09 August was 22.85%, suggesting the stock is oversold, with historical volatility in this time frame at 109.58%.

As of today, CERS’s price is $2.21 -34.45% or -$1.03 from its 5-day moving average. CERS is currently trading -21.69% lower than its 20-day SMA and -33.90% lower than its 100-day SMA. However, the stock’s current price level is +1.04% above the SMA50 and -44.60% below the SMA200.

The stochastic %K and %D were 1.01% and 6.59%, respectively, and the average true range (ATR) was 0.20. With the 14-day stochastic at 0.88% and the average true range at 0.19, the RSI (14) stands at 31.07%. The stock has reached -0.50 on the 9-day MACD Oscillator while the 14-day reading was at -0.60.

Analyst Ratings

BTIG Research downgraded Cerus Corporation (NASDAQ: CERS) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for Cerus Corporation (CERS) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CERS, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.

What is CERS’s price target for the next 12 months?

Analysts predict a range of price targets between $3.00 and $9.00, with a median target of $5.50. Taking a look at these predictions, the average price target given by analysts for Cerus Corporation (CERS) stock is $5.75.

Most Popular

Related Posts